During the past decade, Smolensk Regional Hospital- Regional Budget State Healthcare institution conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Smolensk Regional Hospital- Regional Budget State Healthcare institution" are "Cerebral Palsy" (4 trials), "Muscle Spasticity" (4 trials), "Pediatrics" (4 trials) and "Stroke" (2 trials). Many other conditions were trialed in "Smolensk Regional Hospital- Regional Budget State Healthcare institution" in a lesser frequency.

Most popular intervention types in "Smolensk Regional Hospital- Regional Budget State Healthcare institution" are "Biological" (4 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Botulinum Toxin Type A" (2 trials), "Normal Saline (Placebo)" (2 trials) and "botulinum toxin Type A" (2 trials). Other intervention names were less common.

The vast majority of trials in "Smolensk Regional Hospital- Regional Budget State Healthcare institution" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Smolensk Regional Hospital- Regional Budget State Healthcare institution". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Smolensk Regional Hospital- Regional Budget State Healthcare institution, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Smolensk Regional Hospital- Regional Budget State Healthcare institution, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".